Artykuły w czasopismach na temat „Β1-Blockers”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Β1-Blockers”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Bennett, Miriam, Catherina L. Chang, Michael Tatley, Ruth Savage i Robert J. Hancox. "The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports". ERJ Open Research 7, nr 1 (styczeń 2021): 00801–2020. http://dx.doi.org/10.1183/23120541.00801-2020.
Pełny tekst źródłado Vale, Gabriel T., Carla S. Ceron, Natália A. Gonzaga, Janaina A. Simplicio i Júlio C. Padovan. "Three Generations of β-blockers: History, Class Differences and Clinical Applicability". Current Hypertension Reviews 15, nr 1 (29.01.2019): 22–31. http://dx.doi.org/10.2174/1573402114666180918102735.
Pełny tekst źródłaKaroli, N. A., i A. P. Rebrov. "Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease". Kardiologiia 61, nr 10 (30.10.2021): 89–98. http://dx.doi.org/10.18087/cardio.2021.10.n1119.
Pełny tekst źródłaStănciulescu, Maria-Corina, Marius-Călin Popoiu, Anca Maria Cîmpean, Vlad-Laurentiu David, Rodica Heredea, Simona Cerbu i Eugen-Sorin Boia. "Expression of β1 adrenergic receptor in vascular anomalies in children". Journal of International Medical Research 49, nr 9 (wrzesień 2021): 030006052110477. http://dx.doi.org/10.1177/03000605211047713.
Pełny tekst źródłaBarcella, Carlo A., Talip E. Eroglu, Michiel Hulleman, Asger Granfeldt, Patrick C. Souverein, Grimur H. Mohr, Rudolph W. Koster i in. "Association of beta-blockers and first-registered heart rhythm in out-of-hospital cardiac arrest: real-world data from population-based cohorts across two European countries". EP Europace 22, nr 8 (28.06.2020): 1206–15. http://dx.doi.org/10.1093/europace/euaa124.
Pełny tekst źródłaGrande, Fedora, Anna De Bartolo, Maria Antonietta Occhiuzzi, Anna Caruso, Carmine Rocca, Teresa Pasqua, Alessia Carocci, Vittoria Rago, Tommaso Angelone i Maria Stefania Sinicropi. "Carbazole and Simplified Derivatives: Novel Tools toward β-Adrenergic Receptors Targeting". Applied Sciences 11, nr 12 (13.06.2021): 5486. http://dx.doi.org/10.3390/app11125486.
Pełny tekst źródłaArtym, Vira V., i Howard R. Petty. "Molecular Proximity of Kv1.3 Voltage-gated Potassium Channels and β1-Integrins on the Plasma Membrane of Melanoma Cells". Journal of General Physiology 120, nr 1 (10.06.2002): 29–37. http://dx.doi.org/10.1085/jgp.20028607.
Pełny tekst źródłaSingh, Bramah N. "β-Adrenergic Blockers as Antiarrhythmic and Antifibrillatory Compounds: An Overview". Journal of Cardiovascular Pharmacology and Therapeutics 10, nr 4_suppl (październik 2005): S3—S14. http://dx.doi.org/10.1177/10742484050100i402.
Pełny tekst źródłaWinther, K., i C. Hedman. "Beta-Adrenoceptor Blockade, Platelets, and Rheologic Factors". Cephalalgia 6, nr 5_suppl (maj 1986): 33–40. http://dx.doi.org/10.1177/03331024860060s504.
Pełny tekst źródłaDiniz, Gabriela Placoná, Marcela Sorelli Carneiro-Ramos i Maria Luiza Morais Barreto-Chaves. "Thyroid Hormone Increases TGF-β1 in Cardiomyocytes Cultures Independently of Angiotensin II Type 1 and Type 2 Receptors". International Journal of Endocrinology 2010 (2010): 1–7. http://dx.doi.org/10.1155/2010/384890.
Pełny tekst źródłaClemente-Moragón, Agustín, Mónica Gómez, Rocío Villena-Gutiérrez, Doménica V. Lalama, Jaime García-Prieto, Fernando Martínez, Fátima Sánchez-Cabo, Valentín Fuster, Eduardo Oliver i Borja Ibáñez. "Metoprolol exerts a non-class effect against ischaemia–reperfusion injury by abrogating exacerbated inflammation". European Heart Journal 41, nr 46 (7.10.2020): 4425–40. http://dx.doi.org/10.1093/eurheartj/ehaa733.
Pełny tekst źródłaNuttall, S. L., H. C. Routledge i M. J. Kendall. "A comparison of the β1 -selectivity of three β1 -selective β-blockers". Journal of Clinical Pharmacy and Therapeutics 28, nr 3 (czerwiec 2003): 179–86. http://dx.doi.org/10.1046/j.1365-2710.2003.00477.x.
Pełny tekst źródłaWAJIMA, Zen'ichiro. "Future Possibilities for the Clinical Use of β1-blockers". JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA 26, nr 4 (2006): 398–403. http://dx.doi.org/10.2199/jjsca.26.398.
Pełny tekst źródłaNakaya, Michio, Satsuki Chikura, Kenji Watari, Natsumi Mizuno, Koji Mochinaga, Supachoke Mangmool, Satoru Koyanagi i in. "Induction of Cardiac Fibrosis by β-Blocker in G Protein-independent and G Protein-coupled Receptor Kinase 5/β-Arrestin2-dependent Signaling Pathways". Journal of Biological Chemistry 287, nr 42 (10.08.2012): 35669–77. http://dx.doi.org/10.1074/jbc.m112.357871.
Pełny tekst źródłaÁblad, Bengt, i Carl Dahlöf. "Migraine and β-Blockade: Modulation of Sympathetic Neurotransmission". Cephalalgia 6, nr 5_suppl (maj 1986): 7–14. http://dx.doi.org/10.1177/03331024860060s501.
Pełny tekst źródłaBlaauw, Erik, Frans A. van Nieuwenhoven, Peter Willemsen, Tammo Delhaas, Frits W. Prinzen, Luc H. Snoeckx, Marc van Bilsen i Ger J. van der Vusse. "Stretch-induced hypertrophy of isolated adult rabbit cardiomyocytes". American Journal of Physiology-Heart and Circulatory Physiology 299, nr 3 (wrzesień 2010): H780—H787. http://dx.doi.org/10.1152/ajpheart.00822.2009.
Pełny tekst źródłaAshes, Catherine, Saul Judelman, Duminda N. Wijeysundera, Gordon Tait, C. David Mazer, Gregory M. T. Hare i W. Scott Beattie. "Selective β1-Antagonism with Bisoprolol Is Associated with Fewer Postoperative Strokes than Atenolol or Metoprolol". Anesthesiology 119, nr 4 (1.10.2013): 777–87. http://dx.doi.org/10.1097/aln.0b013e3182a17f12.
Pełny tekst źródłaPeltenburg, Puck J., Dania Kallas, Johan M. Bos, Krystien V. V. Lieve, Sonia Franciosi, Thomas M. Roston, Isabelle Denjoy i in. "An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia". Circulation 145, nr 5 (luty 2022): 333–44. http://dx.doi.org/10.1161/circulationaha.121.056018.
Pełny tekst źródłaDurgaryan, Ruzan. "C0159 β1 blockers, warfarin and rhythm conversion in atrial fibrillation". Thrombosis Research 130 (październik 2012): S173. http://dx.doi.org/10.1016/j.thromres.2012.08.188.
Pełny tekst źródłaFedorov, V. N., V. P. Vdovichenko, M. K. Korsakov, V. V. Strakhov, A. A. Popova, A. I. Khokhlov i S. S. Suleymanov. "Pharmacotherapy of glaucoma in terms of evidence-based medicine". Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice, nr 3 (20.10.2023): 44–54. http://dx.doi.org/10.37489/2588-0519-2023-3-44-54.
Pełny tekst źródłaGeng, Yanyan, Xiaoyu Wang i Karl L. Magleby. "Lack of negative slope in I-V plots for BK channels at positive potentials in the absence of intracellular blockers". Journal of General Physiology 141, nr 4 (25.03.2013): 493–97. http://dx.doi.org/10.1085/jgp.201210955.
Pełny tekst źródłaYi, Sheng, Fernando Pierucci-Alves i Bruce D. Schultz. "Transforming growth factor-β1 impairs CFTR-mediated anion secretion across cultured porcine vas deferens epithelial monolayer via the p38 MAPK pathway". American Journal of Physiology-Cell Physiology 305, nr 8 (15.10.2013): C867—C876. http://dx.doi.org/10.1152/ajpcell.00121.2013.
Pełny tekst źródłaCasabella-Ramón, Sergi, Verónica Jiménez-Sábado, Carmen Tarifa, Sandra Casellas, Tien Tina Lu, Paloma Izquierdo-Castro, Ignasi Gich i in. "Impact of R-Carvedilol on β2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes". Biomedicines 10, nr 7 (21.07.2022): 1759. http://dx.doi.org/10.3390/biomedicines10071759.
Pełny tekst źródłaFarhoumand, Lina S., Hongtao Liu, Theodora Tsimpaki, Ulrike B. Hendgen-Cotta, Tienush Rassaf, Nikolaos E. Bechrakis, Miltiadis Fiorentzis i Utta Berchner-Pfannschmidt. "Blockade of ß-Adrenergic Receptors by Nebivolol Enables Tumor Control Potential for Uveal Melanoma in 3D Tumor Spheroids and 2D Cultures". International Journal of Molecular Sciences 24, nr 6 (20.03.2023): 5894. http://dx.doi.org/10.3390/ijms24065894.
Pełny tekst źródłaWydra, Wioletta, i Marek Kuch. "Nebivolol – a place in the therapy of hypertension in various clinical situations". Medycyna Faktów 14, nr 2 (30.06.2021): 195–200. http://dx.doi.org/10.24292/01.mf.0221.9.
Pełny tekst źródłaVerdecchia, Paolo, Claudio Cavallini, Stefano Coiro, Clara Riccini i Fabio Angeli. "Certainties fading away: β-blockers do not worsen chronic obstructive pulmonary disease". European Heart Journal Supplements 23, Supplement_E (1.10.2021): E172—E176. http://dx.doi.org/10.1093/eurheartj/suab116.
Pełny tekst źródłaFloria, Mariana, Alexandru Florinel Oancea, Paula Cristina Morariu, Alexandru Burlacu, Diana Elena Iov, Cristina Petronela Chiriac, Genoveva Livia Baroi i in. "An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation". Pharmaceutics 16, nr 4 (8.04.2024): 517. http://dx.doi.org/10.3390/pharmaceutics16040517.
Pełny tekst źródłaSchnabel, Petra, Christoph Maack, Florian Mies, Stephan Tyroller, Alexander Scheer i Michael Böhm. "Binding Properties of β-Blockers at Recombinant β1-, β2-, and β3-Adrenoceptors". Journal of Cardiovascular Pharmacology 36, nr 4 (październik 2000): 466–71. http://dx.doi.org/10.1097/00005344-200010000-00008.
Pełny tekst źródłaMizogami, Maki, Ko Takakura i Hironori Tsuchiya. "The interactivities with lipid membranes differentially characterize selective and nonselective β1-blockers". European Journal of Anaesthesiology 27, nr 9 (wrzesień 2010): 829–34. http://dx.doi.org/10.1097/eja.0b013e32833bf5e4.
Pełny tekst źródła&NA;. "The interactivities with lipid membranes differentially characterize selective and nonselective β1-blockers". European Journal of Anaesthesiology 29, nr 5 (maj 2012): 255. http://dx.doi.org/10.1097/eja.0b013e328353b02b.
Pełny tekst źródłaBrizzi, Vittorio, Marco Francioli, Mario Brufani, Luigi Filocamo, Giancarlo Bruni i Paola Massarelli. "Synthesis, binding affinity and selectivity of new β1- and β2-adrenoceptor blockers". Il Farmaco 54, nr 11-12 (listopad 1999): 713–20. http://dx.doi.org/10.1016/s0014-827x(99)00077-4.
Pełny tekst źródłaRizos, Ioannis K., James N. Tsoporis, Ioannis K. Toumpoulis, Vasileios Salpeas, Shehla Izhar, Angelos G. Rigopoulos, Eleftherios A. Sakadakis i Thomas G. Parker. "Antiapoptotic Effect of β1 Blockers in Ascending Thoracic Aortic Smooth Muscle Cells". Journal of Cardiovascular Pharmacology 72, nr 2 (sierpień 2018): 86–96. http://dx.doi.org/10.1097/fjc.0000000000000596.
Pełny tekst źródłaChaudhari, Sarika, Weizu Li, Yanxia Wang, Hui Jiang, Yuhong Ma, Mark E. Davis, Jonathan E. Zuckerman i Rong Ma. "Store-operated calcium entry suppressed the TGF-β1/Smad3 signaling pathway in glomerular mesangial cells". American Journal of Physiology-Renal Physiology 313, nr 3 (1.09.2017): F729—F739. http://dx.doi.org/10.1152/ajprenal.00483.2016.
Pełny tekst źródłaKähönen, Mika, Ritva Ylitalo, Tiit Kööbi, Väinö Turjanmaa i Pauli Ylitalo. "Influences of nonselective, β1-selective and vasodilatory β1-selective β-blockers on arterial pulse wave velocity in normotensive subjects". General Pharmacology: The Vascular System 35, nr 4 (październik 2000): 219–24. http://dx.doi.org/10.1016/s0306-3623(01)00109-4.
Pełny tekst źródłaMiaron, J. O. O., i R. J. Christopherson. "Metabolic responses of the whole body, portal-drained viscera and hindquarter to adrenaline infusion: Effects of nonselective and selective β-adrenoceptor blockade". Canadian Journal of Animal Science 77, nr 2 (1.06.1997): 307–16. http://dx.doi.org/10.4141/a94-082.
Pełny tekst źródłaZhang, Y. Clare, Leping Shen i M. Ian Phillips. "An Antisense β1-Reducer: Repeated Administration Reduces Hypertension and Cardiac Hypertrophy Persistently Without Toxicity or Immune Response". Hypertension 36, suppl_1 (październik 2000): 691. http://dx.doi.org/10.1161/hyp.36.suppl_1.691.
Pełny tekst źródłaOngali, Brice, Nektaria Nicolakakis, Xin-Kang Tong, Clotilde Lecrux, Hans Imboden i Edith Hamel. "Transforming growth factor-β1 induces cerebrovascular dysfunction and astrogliosis through angiotensin II type 1 receptor-mediated signaling pathways". Canadian Journal of Physiology and Pharmacology 96, nr 5 (maj 2018): 527–34. http://dx.doi.org/10.1139/cjpp-2017-0640.
Pełny tekst źródłaPark, Soo Hyun, i Ho Jae Han. "The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells". American Journal of Physiology-Renal Physiology 282, nr 2 (1.02.2002): F228—F237. http://dx.doi.org/10.1152/ajprenal.00080.2001.
Pełny tekst źródłaOzakca, Isil, Ebru Arioglu-Inan, Hrag Esfahani, V. Melih Altan, Jean-Luc Balligand, Gizem Kayki-Mutlu i A. Tanju Ozcelikay. "Nebivolol prevents desensitization of β-adrenoceptor signaling and induction of cardiac hypertrophy in response to isoprenaline beyond β1-adrenoceptor blockage". American Journal of Physiology-Heart and Circulatory Physiology 304, nr 9 (1.05.2013): H1267—H1276. http://dx.doi.org/10.1152/ajpheart.00352.2012.
Pełny tekst źródłaKruik-Kollöffel, Willemien J., Job van der Palen, Carine J. M. Doggen, Marissa C. van Maaren, H. Joost Kruik, Edith M. Heintjes, Kris L. L. Movig i Gerard C. M. Linssen. "Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases". PLOS ONE 15, nr 12 (22.12.2020): e0244231. http://dx.doi.org/10.1371/journal.pone.0244231.
Pełny tekst źródłaGutierrez, Guillermo, i Guillermo Ballarino. "Gut mucosal permeability, β1 receptor blockers and gastric tonometry: the time is now!" Intensive Care Medicine 37, nr 11 (17.08.2011): 1721–22. http://dx.doi.org/10.1007/s00134-011-2330-1.
Pełny tekst źródłaNemoto, Shinji, Yusuke Kasahara, Kazuhiro P. Izawa, Satoshi Watanabe, Kazuya Yoshizawa, Naoya Takeichi, Kentaro Kamiya i in. "Effects of αβ-Blocker Versus β1-Blocker Treatment on Heart Rate Response During Incremental Cardiopulmonary Exercise in Japanese Male Patients with Subacute Myocardial Infarction". International Journal of Environmental Research and Public Health 16, nr 16 (8.08.2019): 2838. http://dx.doi.org/10.3390/ijerph16162838.
Pełny tekst źródłaBrahmbhatt, Shruti Vihang, i Bhagya M. Sattigeri. "A study on management of hypertension in patients with type 2 diabetes mellitus in tertiary care teaching rural hospital". International Journal of Basic & Clinical Pharmacology 7, nr 11 (23.10.2018): 2196. http://dx.doi.org/10.18203/2319-2003.ijbcp20184327.
Pełny tekst źródłaPillozzi, Serena, Marika Masselli, Emanuele De Lorenzo, Benedetta Accordi, Emanuele Cilia, Olivia Crociani, Amedeo Amedei i in. "Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers". Blood 117, nr 3 (20.01.2011): 902–14. http://dx.doi.org/10.1182/blood-2010-01-262691.
Pełny tekst źródłaPolakovičová, M., i R. Čižmáriková. "Molecular Docking Study on the Binding Mode of Cardioselective Phenoxyaminopropanol Blocker into β-adrenergic Receptor Subtypes". Acta Facultatis Pharmaceuticae Universitatis Comenianae 59, nr 2 (28.12.2012): 44–53. http://dx.doi.org/10.2478/v10219-012-0024-6.
Pełny tekst źródłaAhmed, Maruf, Habib Abul Muntasir, Murad Hossain, Masaji Ishiguro, Tadazumi Komiyama, Ikunobu Muramatsu, Hitoshi Kurose i Takafumi Nagatomo. "Beta-Blockers Show Inverse Agonism to a Novel Constitutively Active Mutant of β1-Adrenoceptor". Journal of Pharmacological Sciences 102, nr 2 (2006): 167–72. http://dx.doi.org/10.1254/jphs.fp0060640.
Pełny tekst źródłaSong, Hong Ji, Joongyub Lee, Ye-Jee Kim, Sun-Young Jung, Hwa Jung Kim, Nam-Kyong Choi i Byung-Joo Park. "β1 selectivity of β-blockers and reduced risk of fractures in elderly hypertension patients". Bone 51, nr 6 (grudzień 2012): 1008–15. http://dx.doi.org/10.1016/j.bone.2012.08.126.
Pełny tekst źródłaBrizzi, Vittorio, Marco Francioli, Mario Brufani, Luigi Filocamo, Giancarlo Bruni i Paola Massarelli. "ChemInform Abstract: Synthesis, Binding Affinity, and Selectivity of New β1- and β2-Adrenoceptor Blockers." ChemInform 31, nr 12 (9.06.2010): no. http://dx.doi.org/10.1002/chin.200012248.
Pełny tekst źródłaJia, Haiyan, Sue Monteith i Morris J. Brown. "Expression of the α- and β-Subunits of the Stimulatory and Inhibitory G-Proteins in β1-Adrenoceptor-Blocked and non-β-Adrenoceptor-Blocked Human Atrium". Clinical Science 88, nr 5 (1.05.1995): 571–80. http://dx.doi.org/10.1042/cs0880571.
Pełny tekst źródłaGao, Xiaomeng, Jingyue Chang, Yi Chang, Lili Fan, Ziqian Liu, Cuijuan Zhang, Tatsuo Shimosawa, Fan Yang i Qingyou Xu. "Esaxerenone Inhibits Renal Angiogenesis and Endothelial-Mesenchymal Transition via the VEGFA and TGF-β1 Pathways in Aldosterone-Infused Mice". International Journal of Molecular Sciences 24, nr 14 (21.07.2023): 11766. http://dx.doi.org/10.3390/ijms241411766.
Pełny tekst źródła